Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...

Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders - A Free Webinar from the Brain & Behavior Research Foundation New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders”...

Lenire Biosciences Completes License Agreement with University College London for VSN16R, A Novel Clinical Candidate Treatment for Fragile X Syndrome SAN DIEGO, June 16, 2022 (GLOBE NEWSWIRE) -- Lenire Biosciences Inc., a biopharmaceutical company developing novel treatments for Fragile X Syndrome (FXS) and related disorders, today announced that...

WORLD´S FIRST ONLINE MUSIC SERVICE FOR SPECIAL CHILDREN LAUNCHED BY CANADIAN MUSIC COMPANY ST. CATHARINES, ONTARIO, CANADA, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Specialtones Incorporated, a new Canadian music company focused on applied neuromusicology, today announced the launch of...

WEINBERG FOUNDATION ANNOUNCES $8 MILLION GRANT TOWARD NEW INTERNATIONAL REHABILITATION CENTER BALTIMORE, April 30, 2014 (GLOBE NEWSWIRE) -- The Harry and Jeanette Weinberg Foundation, one of the largest private foundations in the United States, announced today an $8 million grant for the...